Your browser doesn't support javascript.
loading
Infigratinib Reduces Fibroblast Growth Factor 23 (FGF23) and Increases Blood Phosphate in Tumor-Induced Osteomalacia.
Hartley, Iris R; Roszko, Kelly L; Li, Xiaobai; Pozo, Karen; Streit, Jamie; Del Rivero, Jaydira; Magone, M Teresa; Smith, Michaele R; Vold, Roo; Dambkowski, Carl L; Collins, Michael T; Gafni, Rachel I.
Afiliación
  • Hartley IR; National Institute of Dental and Craniofacial Research, NIH Bethesda MD USA.
  • Roszko KL; National Institute of Dental and Craniofacial Research, NIH Bethesda MD USA.
  • Li X; Biostatistics and Clinical Epidemiology, Clinical Center, NIH Bethesda MD USA.
  • Pozo K; National Institute of Dental and Craniofacial Research, NIH Bethesda MD USA.
  • Streit J; National Institute of Dental and Craniofacial Research, NIH Bethesda MD USA.
  • Del Rivero J; National Cancer Institute, NIH Bethesda MD USA.
  • Magone MT; Ophthalmology Consult Services Section National Eye Institute (NEI) Bethesda MD USA.
  • Smith MR; Rehabilitation Medicine Department, Clinical Center, National Institutes of Health Bethesda MD USA.
  • Vold R; QED Therapeutics San Francisco CA USA.
  • Dambkowski CL; QED Therapeutics San Francisco CA USA.
  • Collins MT; National Institute of Dental and Craniofacial Research, NIH Bethesda MD USA.
  • Gafni RI; National Institute of Dental and Craniofacial Research, NIH Bethesda MD USA.
JBMR Plus ; 6(8): e10661, 2022 Aug.
Article en En | MEDLINE | ID: mdl-35991529

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: JBMR Plus Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: JBMR Plus Año: 2022 Tipo del documento: Article Pais de publicación: Reino Unido